Version 1
: Received: 23 December 2020 / Approved: 23 December 2020 / Online: 23 December 2020 (16:12:26 CET)
How to cite:
Duarte, F.; De Oliveira, L. Peri-Implantitis - Decontaminating and Regenerative Treatment Protocol. Preprints2020, 2020120597. https://doi.org/10.20944/preprints202012.0597.v1.
Duarte, F.; De Oliveira, L. Peri-Implantitis - Decontaminating and Regenerative Treatment Protocol. Preprints 2020, 2020120597. https://doi.org/10.20944/preprints202012.0597.v1.
Cite as:
Duarte, F.; De Oliveira, L. Peri-Implantitis - Decontaminating and Regenerative Treatment Protocol. Preprints2020, 2020120597. https://doi.org/10.20944/preprints202012.0597.v1.
Duarte, F.; De Oliveira, L. Peri-Implantitis - Decontaminating and Regenerative Treatment Protocol. Preprints 2020, 2020120597. https://doi.org/10.20944/preprints202012.0597.v1.
Abstract
Peri-implant diseases are defined as pathological inflammatory reactions in the tissue surrounding the osseointegrated implants. They are classified into two categories: mucositis - defined as peri-implant soft tissue inflammation and peri-implantitis - bone loss in the peri-implant region. A clinical case of a 61-years-old woman with an implant in the 46 anatomical position and a 5-year follow-up is presented. A probe depth of 5mm and a bone defect length of 35% was observed. The Implacure® Protocol was applied, with the main objective of eliminating the biofilm present on the exposed implant surface. There are multiple approaches to treat peri-implant diseases. While non-surgical treatment is essential for mucositis control, the treatment of peri-implantitis surgical treatment should be considered. Regenerative bone reconstruction promotes bone repair in the defect area and reduces bleeding during probing. To achieve that, autologous fibrin combined with Cerasorb M® was used. The proposed approach in the exposed clinical case involves the application of Implacure® Protocol, whose combination of the physical decontamination technique, together with the use of chlorhexidine and orthophosphoric acid, added with the combination Piperacillin + Tazobactam together with hyaluronic acid, provide a base that allows to regenerate bone using platelet-rich fibrin with Cerasorb M® and increase the survival time of the implant.
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.